Clinical trials
Monitoring clinical trials
Below are recruiting monitoring clinical trials, each written for real people, not researchers. We’re tracking 1,259 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07641582Recruiting
Gene Testing to Predict Heart Rhythm Problems
This study uses a genetic test to identify who might develop atrial fibrillation (an irregular heartbeat) in the future. Researchers believe certain genetic patterns combined with health factors can help predict this condition early, which could lead to better prevention.
IncheonAges 20–79 - NCT07645898Recruiting
Glucose monitoring study of cornstarch in glycogen storage disease
This study uses a glucose monitor (a small sensor you wear) to measure how your blood sugar responds after eating raw cornstarch, a common treatment for glycogen storage disease type I. The goal is to understand how well cornstarch helps keep your blood sugar steady.
Naples, NapoliAges 18 years+ - NCT07655076RecruitingEarly Phase 1
Smart insulin delivery study for type 1 diabetes
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
Toronto, OntarioAges 18 years+ - NCT07657598Recruiting
Fluid monitor for children having skull surgery
This study checks if a special monitor (called Pleth Variability Index) helps doctors manage fluids better during surgery for children with craniosynostosis. It may lead to safer recovery for your child.
Istanbul, BasaksehirAges Up to 6 years - NCT07665320Recruiting
Monitoring DVT treatment with a new skin sensor
This study tests a new, non-invasive skin sensor that uses electrical currents to see how well clot-busting medication is working in people with deep vein thrombosis (a blood clot in the leg). The goal is to make monitoring easier and more comfortable.
TampereAges 18 years+ - NCT07671742Recruiting
Monitoring heart failure without needles in the hospital
This study tests a new device that checks your heart without needles while you are in the hospital for heart failure. It may replace some blood tests and help doctors make treatment decisions more easily.
LundAges 18 years+ - NCT07631442Enrolling by invitation
Digital Health Monitoring for Primary Biliary Cholangitis
This study uses a smartphone app or digital platform to track how you're feeling day-to-day if you have primary biliary cholangitis (PBC), a liver condition where your immune system damages bile ducts. Researchers want to see if this digital monitoring helps them better understand and manage PBC symptoms.
Redwood City, CaliforniaAges 18 years+ - NCT07518745Enrolling by invitation
Brain Stimulation During Monitoring for Neurological Conditions
This study uses a non-invasive brain stimulation technique called TMS while monitoring your brain activity through electrodes you already have implanted for your treatment. Researchers want to learn how brain stimulation affects brain recordings in people being treated for neurological or psychiatric conditions.
Philadelphia, PennsylvaniaAges 21–75 - NCT07495189Enrolling by invitation
Mood, sleep, and brain study
This trial looks at how mood problems and sleep issues affect each other. It compares people with and without these conditions to understand the connection.
Jinan, ShandongAges 18–80 - NCT07487714Enrolling by invitationPhase 4
Comparing amiodarone doses for paroxysmal AF
This study compares three different daily doses of the heart rhythm medication amiodarone to find the most effective one for preventing episodes of paroxysmal atrial fibrillation. Participants will take one of three doses (100, 200, or 400 mg) for up to 12 months, and the study will monitor how well each dose controls the irregular heartbeat.
TomskAges 18–80 - NCT07475052Enrolling by invitation
Heart rate monitoring to predict biologic therapy response in IBD
This study tests whether a wearable heart rate monitor can help predict how well biologic medications work for people with Crohn's disease or ulcerative colitis. If you are starting infliximab or vedolizumab for the first time, you may be eligible.
Xi'an, ShaanxiAges 18–75 - NCT07472023Enrolling by invitationEarly Phase 1
Stem cell therapy for hearing loss and tinnitus
This trial tests a regenerative stem cell treatment for people with hearing loss, tinnitus, or inner ear injury. It aims to see if the therapy can improve hearing or reduce symptoms.
New York, New YorkAges Any age - NCT07468123Enrolling by invitation
Estimating Atrial Fibrillation Risk With a Handheld ECG
This trial uses a simple, handheld ECG device (like a small card) to check your risk for atrial fibrillation, a common irregular heartbeat. You'll record short heart tracings at home, and the study team will review them to find hidden risk factors.
Boston, MassachusettsAges 18–90 - NCT07448233Enrolling by invitation
AI health management for epilepsy in rural areas
This trial tests a smartphone-based AI system to help manage epilepsy long-term in rural areas. It is for people who have had at least one convulsive seizure in the past year and can use a smartphone with a caregiver.
Xi'an, ShaanxiAges 18–65 - NCT07428395Enrolling by invitation
Monitoring during continuous kidney replacement therapy in the ICU
This study tests a new way to monitor patients while they receive continuous kidney replacement therapy (a type of dialysis) in the ICU. It aims to see if this monitoring can be done safely and smoothly, helping doctors track your treatment better.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07422831Enrolling by invitation
Intermittent glucose sensor use for type 2 diabetes
This trial is testing whether using a continuous glucose monitor (CGM) for different lengths of time helps people with type 2 diabetes understand their blood sugar patterns. You won't need to change your current diabetes medications.
Aurora, ColoradoAges 18 years+ - NCT07399912Enrolling by invitation
Home blood pressure check study for hypertension
This trial tests if home monitoring of blood pressure can help guide your doctor's decisions about your care. It might help you manage your hypertension more effectively.
Singapore, SingaporeAges 21 years+ - NCT07345143Enrolling by invitation
AI study for gestational diabetes
This trial uses artificial intelligence to help manage gestational diabetes in pregnant women. It may improve care for women diagnosed early in pregnancy.
São José do Rio Preto, São PauloAges 18–40 - NCT07314190Enrolling by invitation
Blood tests for brain diseases and mental health conditions
This study looks at blood tests to help diagnose and track brain diseases (like Alzheimer's) or mental health conditions. It compares patients to healthy volunteers to find better ways to detect and monitor these illnesses.
BarcelonaAges 18 years+ - NCT07233421Enrolling by invitation
Blood sugar levels in children with Long QT syndrome on beta-blockers
This study looks at how often low blood sugar (hypoglycemia) happens in young children with Long QT syndrome who take beta-blocker medicine. It may help doctors understand if these children need extra monitoring.
HelsinkiAges Up to 7 years - NCT07224542Enrolling by invitation
Smart contact lenses to monitor glaucoma
This study tests a smart contact lens that may help monitor glaucoma by measuring eye pressure. It is looking for people with glaucoma (who already use eye-drop medicine) and healthy adults without glaucoma to see if the lens works well over time.
Bloomington, IndianaAges 22 years+ - NCT07217977Enrolling by invitation
Study testing QbMobile app for ADHD treatment monitoring
This trial tests if a smartphone app called QbMobile can help monitor ADHD treatment. It is for people who are newly diagnosed or not taking ADHD medication.
Mobile, AlabamaAges 6–60 - NCT07214896Enrolling by invitationPhase 2
Humanoid robotics in clinical care for staff and observers
This trial tests whether humanoid robots can help in clinical workflows. You will interact with the robot and provide feedback over 90 days.
New York, New YorkAges Any age - NCT07212764Enrolling by invitation
Tracking infections in kids with FMF using a phone app
This study tests whether a mobile app can help monitor infections in children and teenagers with Familial Mediterranean Fever (FMF). It aims to make it easier for families to track symptoms from home.
Istanbul, FatihAges 8–18
Hear when a new Monitoring trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for monitoring?
- Yes. Clin2 currently lists 1,259 recruiting monitoring studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a monitoring trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a monitoring trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.